Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1987 Jun;205(6):625–633. doi: 10.1097/00000658-198706000-00003

Gastrointestinal lymphoma and sarcoma. A case for aggressive search and destroy.

R B Adkins Jr, H W Scott Jr, J L Sawyers
PMCID: PMC1493071  PMID: 3592804

Abstract

The incidence of sarcomas of the gastrointestinal tract has remained the same, but gastrointestinal lymphomas are gradually contributing a larger percentage of malignant gastrointestinal neoplasms. The authors have examined their more recent experience with these relatively rare lesions. Twenty-eight patients (13 with lymphoma, 15 with sarcoma) have been treated at the Vanderbilt University and the Metropolitan Nashville General Hospital since 1976. There were eight men in the group with lymphoma and six in the group with sarcoma. The average age for patients with lymphoma was 66 years; the average age was 57 years in the patients with sarcoma. Seven patients with lymphoma and eight patients with sarcoma had been treated for 6 months to 3 years for presumed peptic ulcer disease. Eight of these 15 patients were found to have perforated tumors at the time of surgical exploration. Three patients (all in the group with sarcoma) had metastatic liver disease or peritoneal implants at the time of diagnosis. Treatment for most patients included resection of the tumor, followed by chemotherapy or radiation in cases of tumor perforation or metastatic disease. The survival rate for patients with lymphoma has averaged 5.5 years, with a 55% 5-year survival rate. Patients with cleaved cell tumors survived longer than those with other types of lymphoma. In the group with sarcoma, the survival rate has been 3.1 years on the average, with a 21% 5-year survival rate.

Full text

PDF
625

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appleman H. D., Helwig E. B. Gastric epithelioid leiomyoma and leiomyosarcoma (leiomyoblastoma). Cancer. 1976 Aug;38(2):708–728. doi: 10.1002/1097-0142(197608)38:2<708::aid-cncr2820380215>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  2. Bedikian A. Y., Khankhanian N., Heilbrun L. K., Valdivieso M. Primary lymphomas and sarcomas of the stomach. South Med J. 1980 Jan;73(1):21–24. doi: 10.1097/00007611-198001000-00010. [DOI] [PubMed] [Google Scholar]
  3. Bedikian A. Y., Khankhanian N., Valdivieso M., Heilbrun L. K., Benjamin R. S., Yap B. S., Nelson R. S., Bodey G. P. Sarcoma of the stomach: clinicopathologic study of 43 cases. J Surg Oncol. 1980;13(2):121–127. doi: 10.1002/jso.2930130207. [DOI] [PubMed] [Google Scholar]
  4. Burgess J. N., Dockerty M. B., ReMine W. H. Sarcomatous lesions of the stomach. Ann Surg. 1971 May;173(5):758–766. doi: 10.1097/00000658-197105000-00015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Contreary K., Nance F. C., Becker W. F. Primary lymphoma of the gastrointestinal tract. Ann Surg. 1980 May;191(5):593–598. doi: 10.1097/00000658-198005000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Craig O., Gregson R. Primary lymphoma of the gastrointestinal tract. Clin Radiol. 1981 Jan;32(1):63–72. doi: 10.1016/s0009-9260(81)80257-7. [DOI] [PubMed] [Google Scholar]
  7. DAWSON I. M., CORNES J. S., MORSON B. C. Primary malignant lymphoid tumours of the intestinal tract. Report of 37 cases with a study of factors influencing prognosis. Br J Surg. 1961 Jul;49:80–89. doi: 10.1002/bjs.18004921319. [DOI] [PubMed] [Google Scholar]
  8. Elder J. B., Ganguli P. C., Gillespie I. E. Cimetidine and gastric cancer. Lancet. 1979 May 12;1(8124):1005–1006. doi: 10.1016/s0140-6736(79)92757-0. [DOI] [PubMed] [Google Scholar]
  9. Fitch D. D., Wilson J. A. Primary gastrointestinal lymphoma. South Med J. 1985 Aug;78(8):909–913. doi: 10.1097/00007611-198508000-00004. [DOI] [PubMed] [Google Scholar]
  10. Kieffer R. W., McSwain B., Adkins R. B., Jr Sarcoma of the gastrointestinal tract: a review of 40 cases. Am Surg. 1982 Apr;48(4):167–169. [PubMed] [Google Scholar]
  11. Lee Y. T. Leiomyosarcoma of the gastro-intestinal tract: general pattern of metastasis and recurrence. Cancer Treat Rev. 1983 Jun;10(2):91–101. doi: 10.1016/0305-7372(83)90007-5. [DOI] [PubMed] [Google Scholar]
  12. Lindsay P. C., Ordonez N., Raaf J. H. Gastric leiomyosarcoma: clinical and pathological review of fifty patients. J Surg Oncol. 1981;18(4):399–421. doi: 10.1002/jso.2930180409. [DOI] [PubMed] [Google Scholar]
  13. Lukes R. J., Collins R. D. Lukes-Collins classification and its significance. Cancer Treat Rep. 1977 Sep;61(6):971–979. [PubMed] [Google Scholar]
  14. Lukes R. J., Collins R. D. New approaches to the classification of the lymphomata. Br J Cancer Suppl. 1975 Mar;2:1–28. [PMC free article] [PubMed] [Google Scholar]
  15. McSwain B., Beal J. M. Lymphosarcoma of the Gastro-Intestinal Tract: Report of Twenty Cases. Ann Surg. 1944 Jan;119(1):108–123. [PMC free article] [PubMed] [Google Scholar]
  16. Nance F. C., Cohn I., Jr The management of leiomyosarcoma of the stomach. Surg Clin North Am. 1970 Oct;50(5):1129–1136. doi: 10.1016/s0039-6109(16)39251-9. [DOI] [PubMed] [Google Scholar]
  17. Paulson S., Sheehan R. G., Stone M. J., Frenkel E. P. Large cell lymphomas of the stomach: improved prognosis with complete resection of all intrinsic gastrointestinal disease. J Clin Oncol. 1983 Apr;1(4):263–269. doi: 10.1200/JCO.1983.1.4.263. [DOI] [PubMed] [Google Scholar]
  18. ReMine W. H. Gastric sarcomas. Am J Surg. 1970 Sep;120(3):320–323. [PubMed] [Google Scholar]
  19. Rosenfelt F., Rosenberg S. A. Diffuse histiocytic lymphoma presenting with gastrointestinal tract lesions. The Stanford experience. Cancer. 1980 Apr 15;45(8):2188–2193. doi: 10.1002/1097-0142(19800415)45:8<2188::aid-cncr2820450830>3.0.co;2-e. [DOI] [PubMed] [Google Scholar]
  20. Sandler R. S. Has primary gastric lymphoma become more common? J Clin Gastroenterol. 1984 Apr;6(2):101–107. doi: 10.1097/00004836-198404000-00001. [DOI] [PubMed] [Google Scholar]
  21. Sandler R. S. Primary gastric lymphoma: a review. Am J Gastroenterol. 1984 Jan;79(1):21–25. [PubMed] [Google Scholar]
  22. Shiu M. H., Farr G. H., Papachristou D. N., Hajdu S. I. Myosarcomas of the stomach: natural history, prognostic factors and management. Cancer. 1982 Jan 1;49(1):177–187. doi: 10.1002/1097-0142(19820101)49:1<177::aid-cncr2820490136>3.0.co;2-k. [DOI] [PubMed] [Google Scholar]
  23. Starr G. F. Pathologic features of smooth-muscle tumors. JAMA. 1974 Aug 26;229(9):1219–1220. [PubMed] [Google Scholar]
  24. Taylor R. H., Menzies-Gow N., Lovell D., La Brooy S. J., Misiewicz J. J. Misleading response of malignant gastric ulcers to cimetidine. Lancet. 1978 Apr 1;1(8066):686–688. doi: 10.1016/s0140-6736(78)90799-7. [DOI] [PubMed] [Google Scholar]
  25. Waterhouse G., Skudlarick J. L., Adkins R. B. A clinical review of small bowel neoplasms. South Med J. 1981 Oct;74(10):1201–1203. doi: 10.1097/00007611-198110000-00011. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES